LensAR laser system cleared by FDA for cataract surgery procedures
LensAR has now earned U.S. FDA 510(k) clearance for its LensAR Laser System for anterior capsulotomy and lens fragmentation during cataract surgery.
LensAR (Orlando, FL) has now earned U.S. FDA 510(k) clearance for its LensAR Laser System for lens fragmentation during cataract surgery. The system earned FDA clearance for anterior capsulotomy back in May 2010.
The LensAR Laser System uses proprietary 3D-CSI confocal structured illumination imaging and biometry technology, which images and analyzes the anatomy across all grades of cataract to improve proficiency, according to the company. 3D-CSI provides clean, low-noise images that are both high-contrast and high-resolution from the anterior surface of the cornea to the posterior capsule. The system creates an exact capsulotomy incision size and placement based on introcular lens (IOL) selection and fragments high-grade cataracts for to facilitate removal.
The system has been used in more than 500 eyes outside the U.S. to date.
Posted by Lee Mather
Follow OptoIQ on your iPhone; download the free app here.
Subscribe now to BioOptics World magazine; it's free!